FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileGridAI Technologies Corp.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
GRDX
GridAI Technologies Corp. Stock AnalysisComprehensive stock analysis for GridAI Technologies Corp. (GRDX) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisGRDX
GRDX
GridAI Technologies Corp.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
GRDX
  1. Home
  2. Stocks
  3. GridAI Technologies Corp.

GridAI Technologies Corp.

🇺🇸GRDX•NASDAQ

GridAI Technologies Corp.

🇺🇸GRDX•NASDAQ
Market cap
$32.44M

Your view on GRDX

Mkt Cap
$32.44M
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About GridAI Technologies Corp.

Industry
Biotechnology
Sector
Healthcare
CEO
Jason David Sawyer
Headquarters
GB
Industry
Biotechnology
Sector
Healthcare
CEO
Jason David Sawyer
Headquarters
GB
Description

GridAI Technologies Corp. is a clinical stage biopharmaceutical company, which engages in the research and development of targeted, non-systemic therapies for the treatment of patients with gastrointestinal diseases. Its pipeline includes Latiglutenase, Capeserod, Adrulipase, and Niclosamide.

The company was founded on January 30, 2014 and is headquartered in Boca Raton, FL.

Financial Data

Stock Data

Price chart, volume, and trading data.

What moved it

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for GridAI Technologies Corp.. Starting points for GridAI Technologies Corp.: EPS -$1.94, beta 1.68 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for GridAI Technologies Corp.. Trailing twelve-month EPS for GridAI Technologies Corp. stands at -$1.94. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Wall Street analysts· not FRC research
Nov 22, 2026

Buy

Analyst ratings

1 rating
  • Strong Buy0
  • Buy1
  • Hold0
  • Sell0
  • Strong Sell0
More →

Earnings per share estimates

Per shareThis quarterDec 2026Next quarterMar 2027This yearYear to Dec 2026Next yearYear to Dec 2027
Average estimate−$9,450.00−$10,080.00−$5.22−$4.95
Lowest estimate−$9,450.00−$10,080.00−$5.22−$4.95
Highest estimate−$9,450.00−$10,080.00−$5.22−$4.95
Number of analysts1111
A year ago—−$0.821−$4.16—
Growth vs a year ago——−25.5%—

1The year-ago figure includes one-time items, so growth is not shown.

Revenue estimates

TotalThis quarterDec 2026Next quarterMar 2027This yearYear to Dec 2026Next yearYear to Dec 2027
Average estimate$38110.00$38110.00$22.27M$27.51M
Lowest estimate$38110.00$38110.00$22.27M$27.51M
Highest estimate$38110.00$38110.00$22.27M$27.51M
Number of analysts1111
A year ago—$38208.00$36251.00—
Growth vs a year ago—−0.3%+61319.0%—

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for GridAI Technologies Corp.. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold GRDX18 companies · 2 funds
Compare GRDX with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis
Peer companies
TickerTypeCompanySectorIndustryMkt cap
ALLRAllarity Therapeutics, Inc.HealthcareBiotechnology$12.6M
ASBPAspire Biopharma Holdings, Inc.HealthcareBiotechnology$822,602
BCTXBriaCell Therapeutics Corp.HealthcareBiotechnology$26.7M
CINGCingulate Inc.HealthcareBiotechnology$67.5M
CRISCuris, Inc.HealthcareBiotechnology$832,650
CTXRCitius Pharmaceuticals, Inc.HealthcareBiotechnology$14.0M
More Biotechnology companies
TickerTypeCompanySectorExchangeMkt cap
PCSAProcessa Pharmaceuticals, Inc.HealthcareNASDAQ$4.4M
PCVXVaxcyte, Inc.HealthcareNASDAQ$8.8B
PDSBPDS Biotechnology CorporationHealthcareNASDAQ$43.4M
PEPGPepGen Inc.HealthcareNASDAQ$261.8M
PFNDPathfinder Cell Therapy, Inc.HealthcareOTC$66,716
PGENPrecigen, Inc.HealthcareNASDAQ$1.5B
PHARPharming Group N.V.HealthcareNASDAQ$814.5M
PHATPhathom Pharmaceuticals, Inc.HealthcareNASDAQ$378.8M
PHGUFPharming Group N.V.HealthcareOTC$1.1B
PHIOPhio Pharmaceuticals Corp.HealthcareNASDAQ$7.8M
PHMMFPharma Mar, S.A.HealthcareOTC$1.5B
PHRM.CNPharmaTher Holdings Ltd.HealthcareCNQ$9.1M
ETFs holding GridAI Technologies Corp.
TickerFundFund assets% of the fund
VXFVanguard Extended Market ETF$30.2B in assets0.00%
DFSUDimensional - US Sustainability Core 1 ETF$2.3B in assets0.00%

Largest holders first, then the funds most concentrated in GRDX.

Open Comparable Analysis
Ownership & News

Institutional Ownership

Which funds and firms own the stock.

About this section

Which institutions hold GridAI Technologies Corp., and how their positions are changing. At a $32.4M market value, institutional positions materially move GridAI Technologies Corp.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by GridAI Technologies Corp. executives and directors. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for GridAI Technologies Corp.. Coverage tracks GridAI Technologies Corp. within Biotechnology (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of GridAI Technologies Corp.

GRDX AnalysisFair
Past
2
Growth
2
Health
4
Profit
1
Value
1